PI Discretion

OTHER3 trials

Sponsors

Amgen

Conditions

Lung CancerNeutropeniaNon-Small Cell Lung CancerOvarian Cancer

Phase 2

Evaluating Pegfilgrastim and a Multi-Day Topotecan Regimen in Subjects With Relapsed or Refractory Ovarian Cancer

CompletedNCT00113789

AmgenOvarian Cancer

Start: 2003-10-31End: 2005-04-30Updated: 2009-02-13

Phase 4

FIRST - Study of Pegfilgrastim Administered in the First and Subsequent Cycles of Myelosuppressive Chemotherapy

CompletedNCT00125723

AmgenNeutropenia

Start: 2004-05-31End: 2005-12-31Updated: 2010-12-23

Unknown Phase

Pegfilgrastim Given Same Day As or Day After Carboplatin and Docetaxel in Advanced Metastatic Non-Small Cell Lung Cancer (NSCLC)

CompletedNCT00094822

AmgenLung Cancer, Non-Small Cell Lung Cancer

Start: 2003-07-31End: 2006-02-28Updated: 2009-02-13